[Skip to Content]
[Skip to Content Landing]
Citations 0
Health Agencies Update
April 28, 2004

Osteoarthritis Initiative

JAMA. 2004;291(16):1951. doi:10.1001/jama.291.16.1951-a

A new public-private partnership between the National Institutes of Health and the pharmaceutical industry is establishing a program to hasten discovery of biological markers for osteoarthritis.

Biological specimens, images, and clinical data will be collected from men and women aged 45 years or older at risk for developing osteoarthritis or those with early stages of the disease. Scientists hope to identify new biological markers that indicate changes in bone or cartilage, which may help in the diagnosis and treatment of osteoarthritis.

First Page Preview View Large
First page PDF preview
First page PDF preview